Abstract:Abstract Background Diabetic cardiomyopathy (DCM) contributes to type-II diabetics (T2DM) patient mortality. However, the molecular mechanism of DCM remains unclarified. Results The present study analyzed the differentially expressed genes (DEGs) related to the occurrence and development of DCM. Furthermore, T2DM rat animal models with different courses of DCM were established, and these were confirmed by the results of the oral glucose tolerance test (OGTT), the blood glucose and lipid profile examination, and M-echocardiographic results. Then, transcriptome sequencing was utilized to screen the DCM-related genes. A total 18,410 genes and 19,184 unigenes in each group obtained the Gene Ontology (GO) annotation. The bioinformatics analysis results revealed that there were 360 DEGs in the 8w-T2DM group, including 191 upregulated genes and 169 downregulated genes, and 381 DEGs in the 16w-T2DM group, including 258 upregulated genes and 123 downregulated genes. The DEGs were enriched in 19 cellular components, 21 molecular functions, and 22 biological processes. The KEGG pathway analysis results revealed the in the 8w-T2DM group, the DEGs were enriched in the pathways of unsaturated fatty acids biosynthesis, PPAR signaling, and fatty acid elongation, degradation and metabolism. In the 16w-T2DM groups, the pathways that enriched the DEGs involved were antigen processing and presentation, complement and coagulation cascades, cell adhesion molecules (CAMs), and viral myocarditis. The upregulated genes, were as follows : Cers1, Acot1, Hmgcs2, NTSR-1, PDK4 and Cxcl13 . The downregulated genes were, as follows: Abcd2 and Fcrl-2 . These were identified as correlated to the occurrence and development of DCM. The differential expression was validated by quantitative polymerase chain (Q-PCR). Conclusions Cers1, the gene involved in lipid metabolism, had the highest Log2FC value and might be considered the DCM-related gene for further investigation. This might help screen for the potential pharmaceutical target for DCM.

Single‐Cell RNA Sequencing Uncovers Pathological Processes and Crucial Targets for Vascular Endothelial Injury in Diabetic Hearts

Differential Expression Profiles of Transfer RNA-Derived Small RNAs and Their Potential Roles in Diabetic Cardiomyopathy

Single-Cell Transcriptomics Reveals Endothelial Plasticity During Diabetic Atherogenesis

Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Analysis of differentially expressed genes related to the development of diabetic cardiomyopathy in the myocardium of type-2 diabetic rats

Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy

MicroRNA Expression Profiles in a Human Induced Pluripotent Stem Cell‐derived Model of Diabetic Cardiomyopathy

Single-Cell RNA Sequencing Profiles Identify Important Pathophysiologic Factors in the Progression of Diabetic Nephropathy

Single-cell sequencing technology in diabetic wound healing: New insights into the progenitors-based repair strategies

Single-Cell Transcriptional Landscape Reveals the Regulatory Network and Its Heterogeneity of Renal Mitochondrial Damages in Diabetic Kidney Disease

Single-cell transcriptomes reveal a molecular link between diabetic kidney and retinal lesions

Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas

Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers

Multi-organ single-cell RNA sequencing in mice reveals early hyperglycemia responses that converge on fibroblast dysregulation

Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease

Pathogenesis Study Based on High-Throughput Single-Cell Sequencing Analysis Reveals Novel Transcriptional Landscape and Heterogeneity of Retinal Cells in Type 2 Diabetic Mice

Single-cell transcriptomics: A new tool for studying diabetic kidney disease

Single-cell RNA sequencing in diabetic kidney disease: a literature review

Single‐cell RNA‐seq with spatial transcriptomics to create an atlas of human diabetic kidney disease

Subcellular microRNAs in diabetic cardiomyopathy